Methotrexate

What is it?

Composition

Methotrexate contains the active substance methotrexate, a folate antagonist from the antimetabolite group. The tablets also contain standard excipients used to form and stabilize the oral dosage form, such as fillers, binders, disintegrants, and lubricants.

How to use?

On this page, Methotrexate is supplied as tablets (pills). Dosing is indication-specific and must be prescribed, but the most safety-critical point for tablets is the schedule.

• Autoimmune conditions (e.g., Rheumatoid Arthritis, psoriasis): typically taken once weekly, not daily
• Onset: improvement is often gradual, with many patients noticing change over several weeks
• Folate support: many regimens add folic acid on a different day to reduce side effects
• High-dose methotrexate is used in oncology with strict protocols and monitoring (including “rescue” strategies), and is not a self-managed approach

How does it work?

• Oral route: take the tablets by mouth with water.
• Dose: use only the prescribed dose, commonly 2.5 mg tablets taken as a once-weekly regimen in autoimmune disease; oncology schedules may use different mg doses set by a specialist.
• Frequency: 1 time per week for rheumatic and inflammatory conditions unless your prescriber gives another schedule.
• Timing: take on the same day each week, preferably after a meal or with food if stomach upset occurs.
• Duration: continue for the full treatment period prescribed by your doctor; do not change the weekly schedule on your own.
• Important handling: do not take it daily unless specifically instructed by a specialist; many regimens require folic acid supplementation on separate days.

Indications

Methotrexate is prescribed across oncology and immune medicine, because those conditions share one theme: cells (immune cells or cancer cells) are multiplying or behaving in an uncontrolled way.

Common uses include:

• Rheumatoid Arthritis (rheumatology): reduces inflammation and helps limit progression as a DMARD
• Psoriasis (dermatology): helps when skin disease is extensive or resistant to topical treatment
• Other Autoimmune Diseases: used in selected cases where immune suppression is needed
• Cancer treatments: included in multiple chemotherapy protocols under specialist care

Comparison

Methotrexate can offer strong disease control for many immune conditions, with a monitoring burden that is higher than simple anti-inflammatory pain relief.

EMA guidance documents for inflammatory arthritis therapies place Methotrexate among core DMARD strategies, with escalation pathways when disease targets are not met ^[5].

Contraindications

Methotrexate is NOT for you in any of these situations, unless a specialist has explicitly decided the benefit outweighs the risk with a defined safety plan:

NOT for you if you want a medicine that works immediately or if you cannot follow weekly dosing and lab monitoring.

• Pregnancy, trying to conceive, or breastfeeding (teratogenic risk and pregnancy loss risk)
• Known hypersensitivity to Methotrexate
• Severe liver disease or significant alcohol-related liver injury
• Severe kidney impairment (reduced clearance increases toxicity risk)
• Active serious infection (bacterial, viral, or fungal), including opportunistic infections
• Pre-existing significant blood disorders with low white cells, platelets, or severe anaemia unless managed under specialist protocols

Interactions that often trigger extra caution include immunosuppressants such as azathioprine, combination DMARD regimens like sulfasalazine, and certain antibiotics that affect folate pathways or kidney clearance.

Not recommended for

Methotrexate is not a good fit if you need something that works right away or if you cannot keep to a weekly plan with regular blood tests. It is also not suitable if you are pregnant, breastfeeding, have serious liver, kidney, or blood problems, or have an active serious infection.

Side effects

Methotrexate can cause side effects because it targets processes used by fast-dividing cells (mouth lining, gut lining, bone marrow, hair follicles) and because it can stress the liver.

Common or expected effects in day-to-day use can include:

• Nausea, reduced appetite, abdominal discomfort
• Mouth sores (stomatitis) or sore throat
• Fatigue after the weekly dose
• Mild hair thinning
• Increased sensitivity to sunlight in some patients

More serious risks need fast action:

• Bone marrow suppression: low white cells (infection risk), low platelets (bruising/bleeding), anaemia (weakness)
• Hepatotoxicity: rising liver enzymes, rarely serious liver injury
• Lung toxicity: new or worsening dry cough, breathlessness, fever (can be drug-related pneumonitis)
• Severe rash, blistering, or extensive skin peeling
• Signs of significant infection (persistent fever, chills, painful urination)

A small, real-world detail: mouth ulcers from Methotrexate often start as “burning gums” or a metallic taste before obvious sores appear. Acting early (prompt review and supportive care) tends to be easier than waiting.

Folate support:

• Folate supplementation is commonly used to reduce mouth sores, nausea, and some lab abnormalities.
• Folic acid is a form of folate and is often scheduled on a different day than Methotrexate.
• Folinic acid (a different form of folate) can be used in rescue strategies, mainly in high-dose protocols.

Drug interactions and combinations seen in practice:

• Azathioprine: combining immunosuppressants can raise infection and blood-count risks; monitoring plans need to be aligned
• Sulfasalazine: sometimes combined in rheumatology, but blood and liver monitoring becomes even more relevant
• Corticosteroids: often used as a short-term bridge while Methotrexate starts working; long-term steroid risk still needs its own plan
• Certain antibiotics (classic example: trimethoprim-containing regimens) can sharply raise toxicity risk with Methotrexate and are treated as a high-alert combination in many protocols ^[4]

Common mistakes

These patterns show up again and again, and they are avoidable.

• Taking Methotrexate daily instead of weekly because it “looks like a normal tablet.” This is the biggest preventable safety problem with Methotrexate.
• Mixing up folic acid timing, then stopping it because they assume it “cancels” Methotrexate. Folic acid supports tolerability without negating the intended effect at standard supplementation doses.
• Ignoring early mouth or throat symptoms. Stomatitis can be an early toxicity clue, not a minor annoyance.
• Using alcohol heavily while on long-term Methotrexate, which stacks liver stress and pushes hepatotoxicity risk in the wrong direction.
• Starting new medicines without flagging Methotrexate, then getting an interaction (classic examples include certain antibiotics and high-dose anti-inflammatory regimens).

One sentence that saves trouble: “This is my weekly Methotrexate day.” It prevents accidental duplication when multiple clinicians are involved.

Doctor opinions

In clinic, rheumatologists often call Methotrexate the “anchor” DMARD for Rheumatoid Arthritis because it has decades of outcomes data and it pairs with many step-up strategies when a single agent is not enough. Dermatologists use it for psoriasis when the burden is high and systemic control is needed, balancing skin benefit against liver and blood risks.

1. The weekly schedule is non-negotiable. Most serious preventable events start with dose confusion.
2. Side effects are often manageable when caught early. Mouth soreness, nausea, or fatigue can improve with folate strategies or dose adjustments.
3. Monitoring is part of the therapy. Blood counts and liver enzymes are tracked because Methotrexate can cause bone marrow suppression and hepatotoxicity.

WHO materials on immunosuppressive therapy and infection risk highlight the same practical message: lowered immunity changes how aggressively infections must be taken and assessed ^[3].

Frequently asked questions

How long does Methotrexate take to work for Rheumatoid Arthritis or psoriasis?

Response time is usually measured in weeks, not days. Many patients start to notice meaningful improvement around 4–8 weeks, with continued gains over 3–6 months when the dose is optimised. NICE guidance in 2025 describes this delayed onset pattern for disease-modifying therapy. The British Society for Rheumatology also notes that response assessment should be time-based rather than day-based.

Oral tablets versus subcutaneous methotrexate

Tablets are convenient and avoid injections, but some patients have more nausea or variable absorption at higher weekly doses. Subcutaneous methotrexate can give steadier exposure and may improve tolerability for people who struggle with gastrointestinal effects. Switching route is a common step before declaring Methotrexate a failure in Rheumatoid Arthritis care pathways. In 2023, the EMA described route and monitoring considerations for systemic therapy, and the American College of Rheumatology has discussed route switching in treatment optimization.

Missed weekly dose actions

If a weekly dose is missed, the safest action depends on how close it is to the next scheduled dose and what else is being taken that week. Many clinicians advise taking the missed dose within 1–2 days, then returning to the usual weekly day, while avoiding doubling up close together. If the next dose day is near, skipping and restarting on the regular day is often chosen to reduce overdose risk. In 2022, MOHAP medication-safety messaging in the UAE treated weekly high-alert medicines as a category where dose-doubling errors should be actively prevented.

Folic acid and folinic acid roles

Folic acid is a form of folate used to reduce common Methotrexate side effects such as mouth sores and nausea, and it is usually taken on a different day than Methotrexate. Folinic acid is a more active folate form and is used as rescue therapy in specific situations, mainly high-dose methotrexate protocols or significant toxicity. The goal is to protect healthy tissues without losing therapeutic effect. In 2021, WHO educational materials on folate-pathway medicines explained why toxicity management often involves folate-based strategies, and the National Cancer Institute has described similar rescue principles.

Alcohol use while taking Methotrexate

Alcohol adds liver stress, and long-term Methotrexate already carries a hepatotoxicity risk for some patients. Many rheumatology clinics advise minimising alcohol or avoiding it entirely, especially if liver enzymes rise or there are other risk factors such as fatty liver. The risk is not only “feeling unwell”; it can show up silently in blood tests first. In 2023, EMA safety information for Methotrexate highlighted liver monitoring as part of routine systemic use, and the FDA label also supports liver surveillance.

High-dose methotrexate and why it is different

High-dose methotrexate is used in cancer treatments under strict protocols, with planned monitoring and supportive measures. It is not an intensified version of the weekly tablet routine used in autoimmune disease; it is a separate oncology strategy with different toxicity prevention steps. Folinic acid rescue and careful kidney support can be part of these regimens. In 2020, specialist protocols referenced by the FDA and 2023 EMA materials treated high-dose methotrexate as a controlled therapy due to toxicity potential.

Do you offer anonymous delivery?

Front view

Side view

Back view

Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (9.4x4.3x0.3 in. or 24x11x0.7 cm) and its contents cannot be seen.